After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a pair of HIV prevention pills.

The Truvada (TDF-FTC) arm was continued until ... A women-controlled method to prevent HIV infection is urgently needed. Microbicides provide real potential to influence the course of the HIV ...

Descovy and Truvada are prescription drugs used to treat and help prevent HIV. Both drugs come as oral tablets that are taken once per day. Truvada is available as a generic drug, while Descovy is ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

Terms of the deal were not disclosed in the case, which involved the government’s patents on Gilead’s HIV drugs Truvada and ...

Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy.

Gilead Sciences, Inc. (NASDAQ:GILD), a leading biopharmaceutical company with a market capitalization of $119.32 billion, has been making significant strides in its core HIV franchise while expanding ...

Leading UK politicians have called for an HIV prevention drug to be made available across the NHS, after a court ruling paved the way for cheap generic versions of Gilead’s Truvada. Conservative ...

The sustainability and success of the implementation of any new prevention ... HIV-infected partners (HIV serodiscordant couples; 1000 couples) Open-label, daily oral Truvada, provided as 'bridge ...

Foster City, California-based Gilead collaborated with the CDC in the mid-2000s to test if Gilead's Truvada could prevent transmission of HIV, the virus that causes AIDS, in addition to treating it.